Patient | Clinical stage | Post-treatment MRI TRG | Post-treatment endoscopy response | Time to surgery (weeks) | Pathologic stage | Radial Margin | Pathologic TRG | NAR |
---|---|---|---|---|---|---|---|---|
1 | T2 N1 | 3 | No post-treatment endoscopy | 18.1 | T3 N1 | Negative | Not assessed | 41.6 |
2 | T2 N1 | – | Complete | – | – | – | – | N/A |
3 | T2 N2 | 3 | No post-treatment endoscopy | 12.9 | T2 N0 | Negative | 1 | 15 |
4 | T2 N2 | 1 | Complete | – | – | – | – | N/A |
5 | T2 N2 | 3 | Not complete | 25.7 | TisN0 | Negative | 0* | 0 |
6 | T3 N0 | 2 | No post-treatment endoscopy | 17.3 | T0 N0 | Negative | 0 | 0.9 |
7 | T3 N0 | 2 | Complete | – | – | – | – | N/A |
8 | T3 N1 | – | No post-treatment endoscopy | 12.3 | T0 N0 | Negative | 0 | 0.9 |
9 | T3 N1 | 2 | Not complete | 13.0 | T3 N0 | Negative | 1 | 15 |
10 | T3 N1 | 2 | Complete | 16.9 | T3 N1 | Negative | 1 | 30.1 |
11 | T3 N1 | 2 | Not complete | 13.6 | T0 N0 | Negative | 0 | 0.9 |
12 | T3 N2 | 2 | Not complete | 23.4 | T3 N2 | Positive | 3 | 50.4 |
13 | T3 N2 | 3 | Not complete | 17.9 | T1 N0 | Negative | 2 | 3.7 |
14 | T3 N2 | 3 | Not complete | 17.3 | T1 N0 | Negative | 3 | 3.7 |
15 | T3 N2 | 1 | Not complete | 13.6 | T0 N0 | Negative | 0 | 0.9 |
16 | T3 N2 | 3 | No post-treatment endoscopy | 14.1 | T2 N1 | Negative | 2 | 20.4 |
17 | T3 N2 | 1 | Complete | – | – | – | – | N/A |
18 | T3 N2 | 2 | No post-treatment endoscopy | 13.9 | T0 N0 | Negative | 0 | 0.9 |
19 | T3 N2 | 2 | Complete | 24.3 | T0 N0 | Negative | 0 | 0.9 |
20 | T3 N2 | 3 | Complete | 18 | T3 N1 | Negative | 2 | 30.1 |
21 | T3 N2 | 3 | Not complete | 13.6 | T3 N1 | Negative | 2 | 20.4 |
22 | T4bN0 | 1 | Complete | – | – | – | – | N/A |
23 | T4aN1 | – | No post-treatment endoscopy | 13 | T0 N0 | Negative | 0 | 0 |
24 | T4aN2 | 3 | Not complete | 13.9 | T3 N1 | Positive | 2 | 20.4 |
25 | T4aN2 | 3 | Not complete | 13.1 | T3 N1 | Negative | 2 | 20.4 |
26 | T4bN2 | 3 | Complete | – | – | – | – | N/A |